Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The purpose of the study was to examine endothelium‐dependent and ‐independent vasodilation of conduit and resistance vessels in sickle cell anemia (HbSS). We measured the effects of intra‐arterial infusion of methacholine, sodium nitroprusside, and NG‐monomethyl‐L‐arginine (L‐NMMA) on forearm blood flow using venous occlusion plethysmography in eight patients with HbSS and 11 HbAA controls. We assessed vasodilation of the conduit brachial artery using ultrasound in 17 patients with HbSS and 41 nonanemic controls. Forearm blood flow response to methacholine was similar in HbSS and HbAA, while the response to sodium nitroprusside was greater in those with HbSS. Nitric oxide synthase inhibition with L‐NMMA attenuated methacholine‐induced forearm blood flow to a lesser extent in HbSS compared to HbAA, suggesting diminished nitric oxide (NO) contribution to endothelium‐dependent vasodilation. Flow‐mediated and nitroglycerin‐induced dilation were impaired in HbSS compared to controls and were not affected by the antioxidant vitamin C or the precursor substrate for NO synthesis L‐arginine. NO bioactivity is reduced but differs in peripheral conduit and resistance vessels in HbSS. Resistance vessels have preserved response to exogenous NO donors but have diminished contribution of NO to endothelium‐dependent vasodilation. Conduit vessels demonstrate impaired vasodilation to endogenous and exogenous NO. Am. J. Hematol. 74:104–111, 2003. © 2003 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866 · cited 1×
“The finding of impaired response of conduit vessels to NO may be particularly important in the carotid circulation—contributing to the reversible cerebral vasculopathy and propensity for stroke observed in children with HbSS [22].”
BackgroundCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330 · cited 2×
“[8] suggested diminished NO bioavailability in HbSS.”
BackgroundAscorbic Acid Reverses Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease
Levine, G. N., Frei, B., Koulouris, S. N., Gerhard, M. D., Keaney, J. F., & Vita, J. A. (1996) · Circulation · doi:10.1161/01.cir.93.6.1107 · Cited by 582 · cited 2×
“In human subjects with coronary artery disease, a 2-g dose has been shown to reverse impaired brachial artery flow-mediated dilation [11].”
BackgroundMethodSelf-citationOxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease
Aslan, M., Ryan, T. M., Adler, B., Townes, T. M., Parks, D. A., Thompson, J. A., Tousson, A., Gladwin, M. T., Patel, R. P., Tarpey, M. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221292098 · Cited by 391 · cited 1×
“This concept is further supported by the observation that NO-mediated dilation may be improved by pretreatment with antioxidant enzymes in models of sickle cell disease [4].”
BackgroundGokce, N., Keaney, J. F., Frei, B., Holbrook, M., Olesiak, M., Zachariah, B. J., Leeuwenburgh, C., Heinecke, J. W., & Vita, J. A. (1999) · Circulation · doi:10.1161/01.cir.99.25.3234 · Cited by 387 · cited 1×
“Endothelium-dependent, flow-mediated, and endothelium-independent nitroglycerin-induced dilation of the conduit brachial artery was determined using vascular ultrasound [11,12].”
MethodSelf-citationAnand, I. S., Chandrashekhar, Y., Wander, G. S., & Chawla, L. S. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00007-q · Cited by 116 · cited 2×
“Hemodynamic consequences of anemia including increased cardiac output and blood flow stimulate NO production and reduce peripheral vascular resistance [ 13 ].”
BackgroundResult
Cited by
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61029-x · Cited by 2,504
Rother, R. P., Bell, L., Hillmen, P., & Gladwin, M. T. (2005) · JAMA · doi:10.1001/jama.293.13.1653 · Cited by 1,557
Kato, G. J., McGowan, V., Machado, R. F., Little, J. A., Taylor, J., Morris, C. R., Nichols, J. S., Wang, X., Poljakovic, M., Morris, S. M., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2373 · Cited by 661
“The first involves the stoichiometric inactivation of nitric oxide by cell-free plasma hemoglobin, associated with impairment of nitric oxide-dependent blood flow in patients with sickle cell disease.(16;25-27;30;35;36) The second involves the release of erythrocyte arginase, which converts plasma L-arginine into orni…”
BackgroundPulmonary Complications of Sickle Cell Disease
Gladwin, M. T., & Vichinsky, E. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0804411 · Cited by 470
Minneci, P. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25040 · Cited by 331
Metadata
- Authors
- Eberhardt, R. T., McMahon, L., Duffy, S. J., Steinberg, M. H., Perrine, S. P., Loscalzo, J., Coffman, J. D., & Vita, J. A.
- Venue
- American Journal of Hematology
- Publisher
- Wiley
- Published
- 2003-09-19
- Volume
- 74
- Issue
- 2
- Pages
- 104-111
- ISSN
- 0361-8609 (ISSN-L)
- 1096-8652
- OpenAlex
- W2069570335
- Cited by
- 113
- References
- 7
- FWCI
- 3.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.